Cancer Research UK logo.
SearchDonate
  • Search

A trial of a drug called NUC-1031 for advanced solid tumours

Overview

Cancer types:

All cancer types

Status:

Results

Phase:

Phase 1

Details

This trial looked at a new drug called NUC-1031. It was for people with a solid tumour that had spread to other parts of the body (advanced cancer). And who had completed all their .

A solid tumour is any type of cancer apart from or .

Recruitment start: 1 October 2012

Recruitment end: 30 June 2015

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Sarah Blagden

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Imperial College London

National Institute for Health Research (NIHR)

NuCana Biomed Ltd

Oxford Cancer Research Centre

Oxford University Hospitals NHS Trust

University of Oxford

Last reviewed: 26 June 2018

CRUK internal database number: 10708

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.